Assignee
HANGZHOU SUMGEN BIOTECH CO LTD
CN·4 granted patents·7 pending applications·5 citations·filing 2019–2023
Top patents by PatentIndex Score
11 records- 0181US11891423B2Fusion protein binding to CD47 protein and application thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2019·Granted Feb 6, 2024·3 cites·9 claims
- 0273US12304967B2Fusion protein and use thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2019·Granted May 20, 2025·1 cites·16 claims
- 0372US11713357B2CD38 protein antibody and application thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2019·Granted Aug 1, 2023·1 cites·7 claims
- 0461US2025206801A1Cd80 protein variant and cd80 fusion proteinHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0559US2023250186A1Cd38 protein antibody and application thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0658US2025026806A1SIRPa VARIANT AND USE THEREOFHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0758US2025019414A1FUSION PROTEIN COMPRISING SIRPa MUTANTHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0856US2024294645A1Bispecific fusion proteinHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0951US12030954B2Antibody binding to AXL protein and application thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2019·Granted Jul 9, 2024·0 cites·14 claims
- 1046US2022306757A1Bcma antibodyHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1146US2022251154A1Fusion protein and use thereofHANGZHOU SUMGEN BIOTECH CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU SUMGEN BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →